• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    HilleVax, Inc. - Common Stock (NQ: HLVX )

    1.910 +0.040 (+2.14%)
    Streaming Delayed Price Updated: 10:59 AM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 39,869
    Open 1.870
    Bid (Size) 1.900 (20)
    Ask (Size) 1.910 (18)
    Prev. Close 1.870
    Today's Range 1.833 - 1.920
    52wk Range 1.550 - 20.22
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    HLVX Stock Earnings: HilleVax Misses EPS for Q2 2024
    HLVX stock results show that HilleVax missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
    From HilleVax, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -87.44%
    -87.44%
    1 Month
    +7.91%
    +7.91%
    3 Month
    +19.37%
    +19.37%
    6 Month
    -86.16%
    -86.16%
    1 Year
    -84.93%
    -84.93%

    More News

    Read More
    HilleVax Announces Reduction in Force
    From HilleVax, Inc.
    Via GlobeNewswire
    HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    (HLVX) - Analyzing HilleVax's Short Interest
    Via Benzinga
    HLVX Stock Earnings: HilleVax Beats EPS for Q4 2023
    Via InvestorPlace
    HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Gold Falls Over 1%; HilleVax Shares Plunge
    Via Benzinga
    Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What's Driving Markets Monday?
    Via Benzinga
    Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    GRFS Stock Alert: Grifols Pops 20% on Takeover Interest
    Via InvestorPlace
    Why Is HilleVax (HLVX) Stock Down 87% Today?
    Via InvestorPlace
    HLVX Investors Have Opportunity to Join HilleVax, Inc. Securities Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Dow Turns Lower; Myomo Shares Jump
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Dow Jumps Over 200 Points; Greenbrier Shares Fall After Q3 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Recap: HilleVax Q4 Earnings
    Via Benzinga
    Vaccine Developer HilleVax Stock Nosedives On Monday - Here's Why
    Via Benzinga
    HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants
    From HilleVax, Inc.
    Via GlobeNewswire
    Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    HLVX Stock Earnings: HilleVax Misses EPS for Q1 2024
    Via InvestorPlace
    HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
    From HilleVax, Inc.
    Via GlobeNewswire
    HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
    From HilleVax, Inc.
    Via GlobeNewswire
    HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
    From HilleVax, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.